An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression. by nantkweststg | Feb 12, 2021
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer. by nantkweststg | Feb 12, 2021
First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial. by nantkweststg | Feb 12, 2021
A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma. by nantkweststg | Feb 12, 2021
Recent Comments